Masashi Hattori, Norifumi Hattori, Goro Nakayama, Shinichi Umeda, Takayoshi Kishida, Yoshihisa Kawase, Kazuhiro Ezaka, Masayuki Tsutsuyama, Mitsuru Sakai, Takeshi Ito, Yutaka Yanbe, Mitsuro Kanda, Chie Tanaka, Kenta Murotani, Masahiko Ando, Yasuhiro Kodera. "Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (RINDO study).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.124